Article thumbnail

Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity

By John S. Hartmann, Hilary Thompson, Haibo Wang, Shami Kanekar, Wei Huang, Steven J. Budd and M. Elizabeth Hartnett

Abstract

Objective: To determine the effects of oxygen fluctuations on pigment epithelial-derived factor (PEDF) and vascular endothelial growth factor (VEGF)/PEDF ratios in a relevant rat model of retinopathy of prematurity (ROP)

Topics: Research Article
Publisher: Molecular Vision
OAI identifier: oai:pubmedcentral.nih.gov:3123158
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol
  2. (2006). Adenoviral vector-delivered pigment epithelium-derived factor for neovascular agerelated macular degeneration: results of a phase I clinical trial. Hum Gene Ther
  3. (2006). Angiostatic Effect of Penetrating Ocular Injury: Role of Pigment Epithelium-Derived Factor. Invest Ophthalmol Vis Sci
  4. (2010). Association of Retinal Vascular Endothelial Growth Factor With Avascular Retina in a Rat Model of Retinopathy of Prematurity. Arch Ophthalmol
  5. (2003). Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics
  6. (2010). Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity.
  7. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia.
  8. (2002). Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in Brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization. Diabetes
  9. (2009). Early Weight Gain Predicts Retinopathy in Preterm Infants: New, Simple, Efficient Approach to Screening. Pediatrics
  10. (2004). Effect of over-expression of pigment epithelium derived factor (PEDF) on developing retinal vasculature in the mouse. Mol Vis
  11. (1954). Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia.
  12. (1999). Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. Life Sci
  13. (1994). Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res
  14. (1942). Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens:(1) Preliminary report.
  15. (2010). Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target Ranges of Oxygen Saturation in Extremely Preterm Infants.
  16. (1997). Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity.
  17. (2002). Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med
  18. (2008). Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina
  19. (2008). Neutralizing antibody to VEGF reduces intravitreous neovascularization and does not interfere with vascularization of avascular retina in an ROP model.
  20. (2001). Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF.
  21. (1996). Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.
  22. (2007). Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood
  23. Oxygen induced retinopathy in the mouse.
  24. (1953). Oxygen studies in retrolental fibroplasia.
  25. (1994). Oxygen-induced retinopathy in the rat: Relationship of retinal nonperfusion to subsequent neovascularization.
  26. (2011). PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel Molecular Vision 2011; 17:1577-1587 ©
  27. (2003). PEDF: A multifacted neurotrophic factor.
  28. (1993). Perinatal factors associated with retinopathy of prematurity. Acta Paediatr
  29. (2006). Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res
  30. (2008). Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.
  31. (2002). Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGFinduced migration and growth. Invest Ophthalmol Vis Sci
  32. (1999). Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science
  33. (2006). Pigment epitheliumderived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
  34. (2002). Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol
  35. (2001). Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.
  36. (1951). Protein measurement with the folin phenol reagent.
  37. (2009). Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Exp Eye Res
  38. (1981). Retinopathy of prematurity: an estimate of vision loss in the United States–1979. Pediatrics
  39. (1999). Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int
  40. (2006). Specific Involvement of Src Family Kinase Activation in the Pathogenesis of Retinal Neovascularization. Invest Ophthalmol Vis Sci
  41. (2004). Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF. Invest Ophthalmol Vis Sci
  42. (2010). Studies on the Pathogenesis of Avascular Retina and Neovascularization into the Vitreous in Peripheral Severe Retinopathy of Prematurity (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc
  43. (2003). The biology of VEGF and its receptors. Nat Med
  44. (1995). The effect of oxygen on vasoformative cell division: Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci
  45. (1987). The efficiency of simulation-based multiple comparisons. Biometrics
  46. (1993). The limit of viability– neonatal outcome of infants born at 22 to 25 weeks' gestation.
  47. (1948). The mode of development of the vascular system of the retina. With some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc U K
  48. (2009). The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res
  49. (2006). The Retinal Vasculature and Function of the Neural Retina in a Rat Model of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci
  50. (2009). The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. Invest Ophthalmol Vis Sci
  51. (1995). Transcutaneous oxygen levels in retinopathy of prematurity. Lancet
  52. (2006). Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci
  53. (2001). Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
  54. (2002). Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
  55. (2004). Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygeninduced retinopathy. Exp Eye Res
  56. (1993). Variable oxygen exposure causes preretinal neovascularisation in the newborn rat. Invest Ophthalmol Vis Sci
  57. (1997). vascular and neuronal cytogenesis in whole-mounted cat retina. Microsc Res Tech
  58. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
  59. (2004). VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: Relevance to clinical ROP. Mol Vis